Security key
48669G105
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)
CUSIP: 48669G105
Q3 2018 13F Holders as of 30 Sep 2018
- Type / Class
- Equity / American Depositary Shares
- Shares outstanding
- 11,430,535
- Total 13F shares
- 220,931
- Share change
- +114,943
- Total reported value
- $400,102
- Price per share
- $3.24
- Number of holders
- 8
- Value change
- +$60,526
- Number of buys
- 4
- Number of sells
- 3
Report period
Q3 2018
Institutions
8
Top holders
8
KZIA full security history
Newer quarter: Q4 2018
Previous quarter: Q2 2018
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48669G105
Recent filing periods:
Top shareholders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
0.49%
|
55,837
|
$165,000 | — | 30 Jun 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.3%
|
34,325
|
$102,000 | — | 30 Jun 2018 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.07%
|
8,101
|
$24,000 | — | 30 Jun 2018 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
6,443
|
$19,000 | — | 30 Jun 2018 | |
| Cornerstone Wealth Management, LLC |
13F
|
Company |
0.04%
|
4,644
|
$1,432,000 | — | 30 Jun 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,250
|
$4,000 | — | 30 Jun 2018 | |
| RBC Europe Ltd |
13F
|
Company |
0%
|
32
|
$95 | — | 30 Jun 2018 |
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) as of Q3 2018
As of 30 Sep 2018,
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
220,931 shares.
The largest 8 holders included
Carnick & Kubik Group, LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, ACADIAN ASSET MANAGEMENT LLC, Steward Partners Investment Advisory, LLC, and BREWIN DOLPHIN LTD.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
7
Q3 2018 holders
8
Holder diff
1
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 Value $ | Q3 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.